SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS (wt-d6-158.wt.net)
Subject: Bio-Rad Laboratories to Host Fourth International Conference on TSEs December 2, 2004 in Paris, France
Date: November 9, 2004 at 1:26 pm PST

-------- Original Message --------
Subject: Bio-Rad Laboratories to Host Fourth International Conference on TSEs
Date: Tue, 09 Nov 2004 15:34:14 -0600
From: "Terry S. Singeltary Sr."
To: BSE-L
CC: cjdvoice@yahoogroups.com


MEDICAL/PROFESSIONAL CONFERENCES

Bio-Rad Laboratories to Host Fourth International Conference on TSEs

International Scientific Experts To Discuss the Evolution of TSEs in
Humans and Animals

MARNES-LA-COQUETTE, France, November 09, 2004 /PRNewswire-FirstCall/ --
Bio-Rad Laboratories, Inc. (


AMEX:BIO
)
(AMEX:and
)
(AMEX:BIOb
)
, a multinational manufacturer and distributor of life science research
products and clinical diagnostics, announced today that it will host its
fourth international conference on Transmissible Spongiform
Encephalopathies (TSEs) on December 2, 2004 in Paris, France.

"This conference continues to attract an outstanding group of scientists
and has proven to be an effective forum for exchanging the latest
information on this rapidly developing field of research," said Brad
Crutchfield, Bio-Rad Vice President of Life Science.

Comprehensive Conference Program To Focus On Latest Research, Diagnostics

The conference will open with presentations on the latest advancements
in research on prions and new trends in TSE diagnostics. Scientific
presentations will include TSE infectivity and PrPsc in blood, human
TSEs and the vCJD epidemic, TSE decontamination and safety issues and an
update on the presence of PrPsc in mammalian muscle. Scientific
specialists presenting their research include Prof. James Ironside
(Imperial College of Edinburgh), Dr. Paul Brown (U.S. National
Institutes of Health), Dr. Jean-Philippe Deslys (French Atomic Energy
Commission) and Dr. Olivier Andreoletti (French National Institute for
Agri-food Research, French National Veterinary School).

The conference will also feature two panel discussions. The first panel
discussion will focus on the difficulties of TSE diagnosis in sheep and
goats, moderated by Dr. Jim Hope (U.K. Veterinary Laboratory Agency) and
the second will provide an update on the key issues in today's BSE
testing environment, moderated by Dr. Jacques Grassi (French Atomic
Energy Commission). The difficulties encountered in the diagnosis of TSE
in sheep and goats will be explored by Dr. Sylvie L. Benestad
(Veterinaerinstituttet, Norway), Dr. Thierry Baron (French Food Safety
Agency), Dr. Hubert Laude (French National Institute for Agricultural
Research) and Prof. Alexandre J. Galo (National Laboratory of Veterinary
Science, Portugal). Sharing their views and experiences on today's BSE
testing situation in Japan, the United States and Britain will be: Dr.
Takashi Onodera (University of Tokyo, Japan), Dr. William Hueston
(Center for Animal Health and Food Safety at the University of
Minnesota, U.S.) and Dr. Peter Soul (U.K. Department for Environment
Food and Rural Affairs).

The TSE conference will be held at the Espace Pierre Cardin located at
1-3 avenue Gabriel, 75008, from 2.00 - 6.30 pm. For more information
send an email to: . www.tse.meeting@bio-rad.com
">www.tse.meeting@bio-rad.com


Bio-Rad Laboratories, Inc. (http://www.bio-rad.com/) is a multinational
manufacturer and distributor of life science research products and
clinical diagnostics. It is based in Hercules, California, and serves
more than 70,000 research and industry customers worldwide through a
network of more than 30 wholly owned subsidiary offices. For more than
50 years, Bio-Rad has provided

innovative technological solutions to help accelerate the pace of
scientific discovery and protect human health.

Various statements made within this press release may constitute
"forward- looking statements" for purposes of the Securities and
Exchange Commission's "safe harbor" provisions under the Private
Securities Litigation Reform Act of 1995 and Rule 3b-6 under the
Securities Exchange Act of 1934. The forward- looking statements
contained herein involve risks and uncertainties that could cause
results to differ materially from the Company's expectations.

CONTACT: Guillaume Camard, Communication Manager, of
Bio-RadLaboratories, Inc. - France, + 33 01 47 95 62 61 or
guillaume_camard@bio-rad.com ; or
Susan Berg, Corporate Communications, ofBio-Rad Laboratories, Inc. -
USA, +1-510-741-6063 or susan_berg@bio-rad.com


Web site: http://www.bio-rad.com/

Ticker Symbol: (AMEX:BIO),(AMEX:BIOb)

Terms and conditions of use apply
Copyright © 2004 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

guillaume_camard@bio-rad.com

http://www.pharmalive.com/News/index.cfm?articleid=189040&categoryid=63

Bio-Rad Laboratories to Host Fourth International Conference on TSEs

International Scientific Experts To Discuss the Evolution of TSEs in
Humans and Animals

MARNES-LA-COQUETTE, France, Nov. 9 /PRNewswire-FirstCall/ -- Bio-Rad
Laboratories, Inc. (AMEX:BIO)(AMEX:and)(AMEX:BIOb), a multinational
manufacturer and distributor of life science research products and
clinical diagnostics, announced today that it will host its fourth
international conference on Transmissible Spongiform Encephalopathies
(TSEs) on December 2, 2004 in Paris, France.
"This conference continues to attract an outstanding group of
scientists and has proven to be an effective forum for exchanging the
latest information on this rapidly developing field of research,"
said Brad Crutchfield, Bio-Rad Vice President of Life Science.
Comprehensive Conference Program To Focus On Latest Research, Diagnostics
The conference will open with presentations on the latest advancements
in research on prions and new trends in TSE diagnostics. Scientific
presentations will include TSE infectivity and PrPsc in blood, human
TSEs and the vCJD epidemic, TSE decontamination and safety issues and an
update on the presence of PrPsc in mammalian muscle. Scientific
specialists presenting their research include Prof. James Ironside
(Imperial College of Edinburgh), Dr. Paul Brown (U.S. National
Institutes of Health), Dr. Jean-Philippe Deslys (French Atomic Energy
Commission) and Dr. Olivier Andreoletti (French National Institute for
Agri-food Research, French National Veterinary School).
The conference will also feature two panel discussions. The first panel
discussion will focus on the difficulties of TSE diagnosis in sheep and
goats, moderated by Dr. Jim Hope (U.K. Veterinary Laboratory Agency) and
the second will provide an update on the key issues in today's BSE
testing environment, moderated by Dr. Jacques Grassi (French Atomic
Energy Commission). The difficulties encountered in the diagnosis of TSE
in sheep and goats will be explored by Dr. Sylvie L. Benestad
(Veterinaerinstituttet, Norway), Dr. Thierry Baron (French Food Safety
Agency), Dr. Hubert Laude (French National Institute for Agricultural
Research) and Prof. Alexandre J. Galo (National Laboratory of Veterinary
Science, Portugal). Sharing their views and experiences on today's
BSE testing situation in Japan, the United States and Britain will be:
Dr. Takashi Onodera (University of Tokyo, Japan), Dr. William Hueston
(Center for Animal Health and Food Safety at the University of
Minnesota, U.S.) and Dr. Peter Soul (U.K. Department for Environment
Food and Rural Affairs).
The TSE conference will be held at the Espace Pierre Cardin located at
1-3 avenue Gabriel, 75008, from 2.00 - 6.30 pm. For more information
send an email to: www.tse.meeting@bio-rad.com.
Bio-Rad Laboratories, Inc. (www.bio-rad.com) is a multinational
manufacturer and distributor of life science research products and
clinical diagnostics. It is based in Hercules, California, and serves
more than 70,000 research and industry customers worldwide through a
network of more than 30 wholly owned subsidiary offices. For more than
50 years, Bio-Rad has provided
innovative technological solutions to help accelerate the pace of
scientific discovery and protect human health.
Various statements made within this press release may constitute
"forward- looking statements" for purposes of the Securities
and Exchange Commission's "safe harbor" provisions under
the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under
the Securities Exchange Act of 1934. The forward- looking statements
contained herein involve risks and uncertainties that could cause
results to differ materially from the Company's expectations.
Quelle: Bio-Rad Laboratories, Inc.


http://www.mysan.de/international/article1551.html


Bio-Rad Laboratories to Host Fourth International Conference on ...

PharmaLive.com (press release), PA - 41 minutes ago
... to be an effective forum for exchanging the latest information on
this rapidly developing field of research," said Brad Crutchfield,
Bio-Rad Vice President of ...

Bio-Rad Laboratories to Host Fourth International Conference on ...

Yahoo News (press release) - 2 hours ago
MARNES-LA-COQUETTE, France, Nov. 9 /PRNewswire-FirstCall/ -- Bio-Rad
Laboratories, Inc. (Amex: BIO - News and BIOb - News), a multinational ...

Bio-Rad Laboratories to Host Fourth International Conference on ...

PR Newswire (press release) - 2 hours ago
... Animals MARNES-LA-COQUETTE, France, Nov. 9 /PRNewswire-FirstCall/ --
Bio-Rad Laboratories, Inc. (Amex: BIO and BIOb), a multinational ...

TSS





Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: